Business · 22/07/2014Updated: 10/17/2026 · 1 min read

FDA to Host Public Meeting on Biomarkers and Pharmacogenomics, Seeks Comments on Proposed Regulations

The US Food and Drug Administration (FDA) is hosting a public meeting to discuss advancements in biomarkers and pharmacogenomics, and is seeking public comments on proposed regulations to advance the use of these technologies in drug development and treatment.